Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale

scientific article published on 13 October 2016

Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ANIE.201607380
P932PMC publication ID5131569
P698PubMed publication ID27736024

P50authorChengqi YiQ56557284
P2093author name stringChuan He
Jinghui Song
Xushen Xiong
Xiaoting Shu
P2860cites workBasis for recognition of cisplatin-modified DNA by high-mobility-group proteinsQ27618787
Cellular processing of platinum anticancer drugsQ29617899
DNA damage in the nucleosome core is refractory to repair by human excision nucleaseQ30969773
Circadian regulation of DNA excision repair: implications for chrono-chemotherapyQ33438273
The effect of chromatin structure on cisplatin damage in intact human cellsQ33617354
Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independentQ33826103
Binding of kinetically inert metal ions to RNA: the case of platinum(II).Q33842478
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistanceQ35083535
HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nucleaseQ35852579
Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.Q36127978
Direct cellular responses to platinum-induced DNA damageQ36800400
Differential DNA lesion formation and repair in heterochromatin and euchromatinQ37220505
DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cellsQ37586327
HMGB proteins: interactions with DNA and chromatinQ37685443
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistanceQ37951497
Measurement of covalent drug-DNA interactions at the nucleotide level in cells at pharmacologically relevant dosesQ38298075
Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adductsQ38329239
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatinQ38329454
Repair of cisplatin--DNA adducts by the mammalian excision nucleaseQ38354253
Nucleotide excision repair is impaired by binding of transcription factors to DNA.Q39853410
Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.Q40320273
Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain.Q42616061
3D-DIP-Chip: a microarray-based method to measure genomic DNA damageQ43114888
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's DiscoveryQ43638582
An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cellsQ43888150
Nucleotide excision repair from site-specifically platinum-modified nucleosomes.Q51836720
Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.Q54111946
Structure, Recognition, and Processing of Cisplatin-DNA Adducts.Q55035583
Differential DNA repair underlies mutation hotspots at active promoters in cancer genomesQ59058533
Synthesis and 1H NMR spectroscopic characterization of trans-[Pt(NH3)2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]]Q69441288
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNAQ69586643
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationQ93607580
P433issue46
P407language of work or nameEnglishQ1860
P304page(s)14246-14249
P577publication date2016-10-13
P1433published inAngewandte Chemie International EditionQ62023953
P1476titleBase-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale
P478volume55

Reverse relations

cites work (P2860)
Q64072657A Chemical Genetic Method for Monitoring Genome-Wide Dynamics of -GlcNAc Turnover on Chromatin-Associated Proteins
Q45961755Chemical Analysis of DNA Damage.
Q53836887Detecting Rare Mutations and DNA Damage with Sequencing-Based Methods.
Q60907403Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs
Q92043229Discovery of Cisplatin Binding to Thymine and Cytosine on a Single-Stranded Oligodeoxynucleotide by High Resolution FT-ICR Mass Spectrometry
Q90617512Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines
Q49962656Force spectroscopy unravels the role of ionic strength on DNA-cisplatin interaction: Modulating the binding parameters.
Q90526979Genome-wide mapping of nucleotide excision repair with XR-seq
Q47875319Genomic Studies Reveal New Aspects of the Biology of DNA Damaging Agents.
Q89350394Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C
Q90184738Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Q89825438Methodologies for detecting environmentally induced DNA damage and repair
Q39016146Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
Q90501007Sequence-Specific Quantitation of Mutagenic DNA Damage via Polymerase Amplification with an Artificial Nucleotide
Q38716555Synthesis, Biological Evaluation, and Molecular Docking Studies on the DNA Binding Interactions of Platinum(II) Rollover Complexes Containing Phosphorus Donor Ligands.